SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Graham Osborn who wrote (57362)6/1/2016 12:35:22 PM
From: richardred  Respond to of 78748
 
RE- Valeant The fact that in the spring Takeda was in interested in jointly acquiring Valeant brings fourth the point of market value relevancy. Based on a competitor in the field that found the event driven price decline, valuation compelling. Many an individual investor might not, but many might, based on the point I mentioned.



To: Graham Osborn who wrote (57362)6/6/2016 7:04:13 PM
From: Spekulatius  Read Replies (1) | Respond to of 78748
 
ENDP is a Valeant (VRX) clone, same business model and similar incentive system plus some folks from VRX left for ENDP. I don't think guilt just by association is a safe assumption, it may share the same issues than VRX.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News